NSE - Delayed Quote INR
Alivus Life Sciences Limited (ALIVUS.NS)
1,040.50
+6.90
+(0.67%)
At close: April 25 at 3:30:02 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
4,135,150
3,060,060
5,975,850
3,881,130
Investing Cash Flow
--
-1,164,830
-1,467,470
-1,222,280
-687,340
Financing Cash Flow
--
-2,794,410
-3,875,930
-787,960
-2,137,810
End Cash Position
--
3,014,140
2,838,230
5,121,570
1,155,960
Capital Expenditure
--
-1,289,690
-1,627,980
-1,321,720
-679,930
Issuance of Capital Stock
--
--
--
10,118,540
--
Free Cash Flow
--
2,845,460
1,432,080
4,654,130
3,201,200
3/31/2021 - 1/13/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade